Corentec Co., Ltd. announced that it expects to receive KRW 2.999888 billion in funding
June 27, 2021
Share
Corentec Co., Ltd announced a private placement of 182,920 common shares of par value KRW 500 per share at an issue price of KRW 16,400 per share for gross proceeds of KRW 2,999,888,000 on June 28, 2021. The transaction will include participation from individual investors Du-hoon Seon, CEO of the company, for 24,390 shares, Seung-hoon Seon, CEO of the company, for 30,487 shares, Kyung-hoon Seon, CEO of the company, for 30,487 shares, Hyeong-hoon Seon for 6,097 shares, Seong-won Yang, executive of the company, for 1,829 shares, Young-beom Heo, outside director of the company, for 1,219 shares, and returning individual investors Min-sik Jo for 30,487 shares, Kyung-jo Min for 30,487 shares, Seung-bok Hong for 18,292 shares, Min-nyeong Kim for 6,097 shares, and Young-kyung Lee for 3,048 shares. The company will issue securities through third party allotment method. All securities to be issued will be subject to a lock-up period of one year. The transaction has been approved by the board of directors of the company and is expected to close on July 28, 2021.
Corentec Co., Ltd. is a Korea-based company engaged in the development, manufacture and sale of orthopedic implants. The Companyâs products consist of hip products, including primary systems, hemi-arthroplasty systems and revision systems, such as cementless femoral stems, cemented femoral stems, cups for acetabular systems, bearing systems and others; knee products, including primary knee system fixed type, primary knee system mobile type, revision knee systems and augments systems, and spine products, including pedicle screws and peek cages. The Company mainly provides its hip products under the brand name of BENCOX, knee products under the brand name of LOSPA and spine products under the brand name of LOSPA IS. The Company distributes its products within domestic market and to overseas markets.
CORENTEC CO., LTD. 
